1xbet live casino 。

Michigan, Ohio State fight broken up with police pepper spray after Wolverines stun Buckeyes 13-10Brown's 17 lead Rhode Island over Charleston (SC) 91-53

With 25 percent of the vote according to two exit polls, Ciolacu appeared to be well ahead of far-right challengers looking to capitalise on this EU member's concerns about inflation and the war in neighbouring Ukraine. The same exit polls gave second place to centre-right former journalist turned small-town mayor Elena Lasconi at 18 percent, with two far-right candidates scoring 15 and 16 percent. In the absence of an outright winner in the first round -- scoring more than 50 percent -- the top two candidates go through to a second-round run-off in the poor NATO member on December 8. Ciolacu, a Social Democrat, is leading a field of 13 contenders in the race to take over from President Klaus Iohannis in the largely ceremonial post. He welcomed the exit polls putting him in the lead, but said all the votes would have to be counted before he knew who he would face in the second round. Lasconi too, was cautious. "The scores are very tight, it's not yet time to celebrate," said the 52-year-old politician. Far-right leader George Simion, 38, who some had forecast might take second place, is for the moment in fourth. Exit polls put him just behind the 62-year-old pro-Russian candidate Calin Georgescu. But Simion said Sunday evening: "We'll see the results of the ballot boxes at 11:00 pm (2100 GMT)." Ciolacu's party has shaped Romania's politics for more than three decades, and as he voted Sunday he promised stability and a "decent" standard of living. But political analyst Cristian Parvulescu told AFP: "The far right is by far the big winner of this election." Simion saw his popularity surge by tapping into voter anger over record inflation while promising more affordable housing. Looking for a new election breakthrough for European far-right parties, Simion warned of possible "fraud" and "foreign interference" when voting. But he added: "I am happy that we are giving Romanians hope and the prospect of a better future." The stakes are high for Romania, which has a 650-kilometre (400-mile) border with Ukraine and has become more important since Russia invaded its neighbour in 2022. The Black Sea nation now plays a "vital strategic role" for NATO -- as it is a base for more than 5,000 soldiers -- and the transit of Ukrainian grain, the New Strategy Center think tank said. Donald Trump's victory in the US presidential election has further "complicated" Romania's choice, political analyst Cristian Pirvulescu told AFP. Known for his fiery speeches, Simion is a Trump fan who sometimes dons a red cap in appreciation of his idol. Simion opposes sending military aid to Ukraine, wants a "more patriotic Romania" and frequently lashes out against what he calls the "greedy corrupt bubble" running the European Union. Having campaigned hard to win over Romania's large diaspora working abroad, he said the country had only "minions and cowards as leaders". Pirvulescu predicted that if Simion reached the second round his AUR party would get a boost in the December parliamentary election. "Romanian democracy is in danger for the first time since the fall of communism in 1989," he said. "I'm really afraid we'll end up with Simion in the second round," 36-year-old IT worker Oana Diaconu told AFP, expressing concern about the far-right leader's unpredictable nature and attacks on the European Union. The campaign was marked by controversy and personal attacks, with Simion facing accusations of meeting with Russian spies -- a claim he has denied. Ciolacu has been criticised for his use of private jets. Some observers had tipped Lasconi, now mayor of the small town of Campulung and head of a centre-right opposition party, as a surprise package. Sunday's exit polls appeared to suggest they were right. During campaigning, she had said she wanted a future "where no one has to pack their suitcases and leave" the country and for "institutions that work". bur/js-jj/Ritu Beri unveils Escape lifestyle store

China launches first Long March 12 from new commercial spaceport in boost for country’s lunar plans

Geode Capital Management LLC boosted its position in Castle Biosciences, Inc. ( NASDAQ:CSTL – Free Report ) by 1.1% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 624,683 shares of the company’s stock after buying an additional 7,004 shares during the period. Geode Capital Management LLC’s holdings in Castle Biosciences were worth $17,820,000 as of its most recent SEC filing. Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quest Partners LLC increased its holdings in shares of Castle Biosciences by 54.4% in the 3rd quarter. Quest Partners LLC now owns 4,318 shares of the company’s stock valued at $123,000 after acquiring an additional 1,522 shares during the last quarter. US Bancorp DE lifted its stake in Castle Biosciences by 1,889.2% during the third quarter. US Bancorp DE now owns 4,615 shares of the company’s stock worth $132,000 after purchasing an additional 4,383 shares during the last quarter. Point72 DIFC Ltd acquired a new position in Castle Biosciences in the third quarter worth $140,000. Assetmark Inc. increased its stake in Castle Biosciences by 16.8% during the third quarter. Assetmark Inc. now owns 5,212 shares of the company’s stock valued at $149,000 after purchasing an additional 748 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its holdings in shares of Castle Biosciences by 64.6% during the third quarter. China Universal Asset Management Co. Ltd. now owns 5,335 shares of the company’s stock worth $152,000 after purchasing an additional 2,093 shares during the period. Institutional investors and hedge funds own 92.60% of the company’s stock. Insider Transactions at Castle Biosciences In other news, insider Derek J. Maetzold sold 9,364 shares of Castle Biosciences stock in a transaction that occurred on Tuesday, December 17th. The shares were sold at an average price of $28.34, for a total value of $265,375.76. Following the transaction, the insider now owns 84,762 shares of the company’s stock, valued at $2,402,155.08. The trade was a 9.95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link . Also, CFO Frank Stokes sold 6,923 shares of the stock in a transaction that occurred on Friday, November 15th. The shares were sold at an average price of $29.93, for a total transaction of $207,205.39. Following the sale, the chief financial officer now directly owns 30,823 shares of the company’s stock, valued at approximately $922,532.39. This represents a 18.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here . In the last 90 days, insiders have sold 35,549 shares of company stock valued at $1,079,871. Corporate insiders own 7.20% of the company’s stock. Wall Street Analyst Weigh In View Our Latest Research Report on CSTL Castle Biosciences Stock Performance CSTL stock opened at $26.83 on Friday. The company has a 50-day simple moving average of $30.49 and a 200 day simple moving average of $27.41. The company has a market capitalization of $751.43 million, a P/E ratio of 134.16 and a beta of 0.92. The company has a quick ratio of 7.64, a current ratio of 7.78 and a debt-to-equity ratio of 0.02. Castle Biosciences, Inc. has a fifty-two week low of $16.97 and a fifty-two week high of $35.84. Castle Biosciences ( NASDAQ:CSTL – Get Free Report ) last issued its quarterly earnings results on Monday, November 4th. The company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.14. Castle Biosciences had a net margin of 1.95% and a return on equity of 1.47%. The company had revenue of $85.78 million during the quarter, compared to analyst estimates of $78.55 million. During the same period in the prior year, the business posted ($0.26) EPS. Sell-side analysts predict that Castle Biosciences, Inc. will post 0.34 earnings per share for the current fiscal year. About Castle Biosciences ( Free Report ) Castle Biosciences, Inc, a molecular diagnostics company, provides testing solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus, uveal melanoma, and mental health conditions. It offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma; DecisionDx-SCC, a proprietary risk stratification GEP test for patients with cutaneous squamous cell carcinoma; MyPath Melanoma, a test used for patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a spatial omics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, or low-grade dysplasia Barrett's esophagus. Featured Stories Want to see what other hedge funds are holding CSTL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Castle Biosciences, Inc. ( NASDAQ:CSTL – Free Report ). Receive News & Ratings for Castle Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castle Biosciences and related companies with MarketBeat.com's FREE daily email newsletter .

(The Center Square) – Eleven states, led by Texas, have sued the three largest institutional investors in the world for allegedly conspiring to buy coal company stocks to control the market, reduce competition and violate federal and state antitrust laws. The lawsuit was filed in U.S. District Court for the Eastern District of Texas Tyler Division and demands a trial by jury. It names as defendants BlackRock, Inc., State Street Corporation, and Vanguard Group, Inc., which combined manage more than $26 trillion in assets. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.WASHINGTON (AP) — President-elect Donald Trump’s allies on Capitol Hill rallied around Pete Hegseth , Trump’s Pentagon pick, on Thursday even as new details surfaced about allegations that he had sexually assaulted a woman in 2017. The GOP embrace of Hegseth came as another controversial Trump nominee, Matt Gaetz, withdrew from consideration for attorney general. Gaetz said it was clear he had become a “distraction" amid pressure on the House to release an ethics report about allegations of his own sexual misconduct. An attorney for two women has said that his clients told House Ethics Committee investigators that Gaetz paid them for sex on multiple occasions beginning in 2017, when Gaetz was a Florida congressman. People are also reading... Fresh questions over the two nominees' pasts, and their treatment of women, arose with Republicans under pressure from Trump and his allies to quickly confirm his Cabinet. At the same time, his transition has so far balked at the vetting and background checks that have traditionally been required. While few Republican senators have publicly criticized any of Trump's nominees, it became clear after Gaetz's withdrawal that many had been harboring private concerns about him. Oklahoma Sen. Markwayne Mullin, who served with Gaetz in the House, said it was a “positive move.” Mississippi Sen. Roger Wicker said it was a “positive development.” Maine Sen. Susan Collins said Gaetz “put country first and I am pleased with his decision.” After meeting with Hegseth, though, Republicans rallied around him. “I think he’s going to be in pretty good shape,” said Wicker, who is expected to chair the Senate Armed Services Committee in the next Congress. Republican senators' careful words, and their early reluctance to publicly question Trump's picks, illustrated not only their fear of retribution from the incoming president but also some of their hopes that the confirmation process can proceed normally, with proper vetting and background checks that could potentially disqualify problematic nominees earlier. Gaetz withdrew after meeting with senators on Wednesday. Sen. Thom Tillis said Gaetz was “in a pressure cooker” when he decided to withdraw, but suggested that it would have little bearing on Trump’s other nominees. “Transactions — one at a time,” he said. As the Hegseth nomination proceeds, Republicans also appear to be betting that they won't face much backlash for publicly setting aside the allegations of sexual misconduct — especially after Trump won election after being found liable for sexual abuse last year. Hegseth held a round of private meetings alongside incoming Vice President JD Vance on Thursday in an attempt to shore up support and told reporters afterward: “The matter was fully investigated and I was completely cleared, and that’s where I’m gonna leave it.” A 22-page police report report made public late Wednesday offered the first detailed account of the allegations against him. A woman told police that she was sexually assaulted in 2017 by Hegseth after he took her phone, blocked the door to a California hotel room and refused to let her leave. The report cited police interviews with the alleged victim, a nurse who treated her, a hotel staffer, another woman at the event and Hegseth. Listen now and subscribe: Apple Podcasts | Spotify | RSS Feed | SoundStack | All Of Our Podcasts Hegseth’s lawyer, Timothy Palatore, said the incident was “fully investigated and police found the allegations to be false.” Hegseth paid the woman in 2023 as part of a confidential settlement to head off the threat of what he described as a baseless lawsuit, Palatore has said. Wicker played down the allegations against Hegseth, a former Fox News host, saying that “since no charges were brought from the authorities, we only have press reports.” Sen. Bill Hagerty, R-Tenn., said after his meeting with Hegseth that he "shared with him the fact that I was saddened by the attacks that are coming his way.” Hagerty dismissed the allegations as “a he-said, she-said thing” and called it a “shame” that they were being raised at all. The senator said attention should instead be focused on the Defense Department that Hegseth would head. It's one of the most complex parts of the federal government with more than 3 million employees, including military service members and civilians. Sexual assault has been a persistent problem in the military, though Pentagon officials have been cautiously optimistic they are seeing a decline in reported sexual assaults among active-duty service members and the military academies. Wyoming Sen. John Barrasso, who will be the No. 2 Republican in the Senate next year, said after his meeting with Hegseth that the nominee is a strong candidate who “pledged that the Pentagon will focus on strength and hard power – not the current administration’s woke political agenda.” Senate Republicans are under pressure to hold hearings once they take office in January and confirm nominees as soon as Trump is inaugurated, despite questions about whether Trump’s choices will be properly screened or if some, like Hegseth, have enough experience for the job. Senate Armed Services Chairman Jack Reed, who will be the top Democrat on the panel next year, said the reports on Hegseth “emphasized the need for a thorough investigation by the FBI on the background of all the nominees.” It takes a simple majority to approve Cabinet nominations, meaning that if Democrats all opposed a nominee, four Republican senators would also have to defect for any Trump choice to be defeated. Trump has made clear he’s willing to put maximum pressure on Senate Republicans to give him the nominees he wants – even suggesting at one point that they allow him to just appoint his nominees with no Senate votes. But senators insist, for now, that they are not giving up their constitutional power to have a say. “The president has the right to make the nominations that he sees fit, but the Senate also has a responsibility for advice and consent,” said Republican Sen. Mike Rounds of South Dakota. In the case of Gaetz, he said, “I think there was advice offered rather than consent.” Get Government & Politics updates in your inbox!

Brown's 17 lead Rhode Island over Charleston (SC) 91-53

Stock market today: Stocks waver in thin trading after US markets reopen following a holiday pause

Oklahoma Democrats mourn Fred Harris, former US senator and presidential candidate